Abnormal genes can cause breast cells to grow out of control and become cancerous. By identifying specific gene mutations in tumors, doctors can provide improved targeted treatment for these breast cancers.

The U.S. Food and Drug Administration (FDA) has plenty of detractors. It's accused of being sluggish and too cumbersome in approving new medications, especially vitally important anti-cancer medications.